Enea AB (publ) (STO:ENEA), is a kr2.1b small-cap, which operates in the IT services industry based in Sweden. As various enterprises look to technology to enable their own transformations, the ...
ROME and MILAN, Jan. 14, 2025 /PRNewswire/ -- Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics.
The primary use of the proceeds is to advance the development and clinical adoption of the Heron® lead, WISE's flagship product for spinal cord stimulation (SCS). The Heron® lead is the first SCS lead ...
The new shareholders will support the industrial development of the cognitive humanoid robot RoBee, the expansion of applications in the manufacturing and healthcare sectors, as well as the ...
Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that can detect traces of tumor circulating in the blood. The core of Tethis' innovation lies in its integrated ...
WISE S.p.A., a pioneering medical device company specializing in advanced implantable electrodes for neuromonitoring, neuromodulation, and brain-computer interface (BCI), today announced the ...